Laboratory for Critical Care Physiology, The Feinstein Institute for Medical Research, Manhasset, NY, USA; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USAInterests: cardiopulmonary resuscitation; airway management; CPR; critical care medicine; mechanical ventilation; inflammation; anesthesiology; emergency management; intensive care medicine; resuscitation
Dear Colleagues,
Cardiac arrest remains a critical medical emergency with a high mortality rate, often leading to a complex clinical condition known as Post-Cardiac Arrest Syndrome (PCAS). PCAS encompasses a range of pathophysiological changes, including neurological deficits, myocardial dysfunction, and systemic inflammation. Despite advancements in resuscitation science and critical care, the management and prognostic assessment of PCAS continues to pose significant challenges for clinicians and researchers. This calls for a comprehensive review that integrates findings from both basic and clinical sciences to offer a holistic understanding of PCAS, its prognostic indicators, and management strategies.
We invite authors to contribute to this special issue titled "Post-Cardiac Arrest Syndrome: Prognostic Performance and Management”. The aim is to collate state-of-the-art reviews and original research that delve into the multifaceted aspects of PCAS, from molecular mechanisms to clinical interventions. Topics may include but are not limited to, neurological outcomes, myocardial recovery, metabolic alterations, and advancements in therapeutic interventions and prognostification. We are particularly interested in reviews that discuss novel biomarkers for prognosis, evidence-based management protocols, and the translational potential of basic science findings to clinical practice.
By bringing together insights from diverse disciplines, this issue aims to serve as a valuable resource for clinicians, researchers, and academicians involved in the study and treatment of PCAS. These contributions will play a pivotal role in advancing our understanding and management of this complex syndrome.
Dr. Kei Hayashida
Guest Editor
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.